Position in AUTL
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$1,851,718
+$293,596 QoQ
Shares Held
1,157,324
+2.5% QoQ
Ownership
0.435%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#16
of 84 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AUTL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Cetera Investment Advisers holds $187,106,390 across 112 Biotechnology names. AUTL ranks #24 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
78,107 | $38,798,090 | |
| 2 | IBRX |
ImmunityBio, Inc.
|
1,140,476 | $9,984,867 | |
| 3 | EXEL |
Exelixis, Inc.
|
169,657 | $9,231,037 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
14,664 | $9,143,590 | |
| 5 | OCUL |
Ocular Therapeutix, Inc
|
785,732 | $7,715,888 | |
| 6 | ARGX |
Argenx SE
|
7,844 | $7,277,427 | |
| 7 | VKTX |
Viking Therapeutics, Inc.
|
184,543 | $7,199,022 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
23,196 | $6,982,691 |
All Filings in AUTL
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,851,718 | 1,157,324 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $1,558,122 | 1,129,074 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $2,188,502 | 1,099,750 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,306,037 | 801,250 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,407,152 | 617,172 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $813,551 | 524,872 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $837,121 | 356,222 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $479,160 | 132,000 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $468,060 | 134,500 | Shares | Sole | 2024-08-22 | |
| 2024-03-31 | $840,762 | 131,781 | Shares | Sole | 2024-05-24 | |
| 2023-12-31 | $846,860 | 131,500 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $312,220 | 134,000 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $321,776 | 135,200 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $260,544 | 141,600 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $261,440 | 137,600 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $289,756 | 135,400 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $359,410 | 127,000 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $518,331 | 124,300 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $595,552 | 114,750 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $688,405 | 105,100 | Shares | Sole | 2021-11-16 | |
| No filing history on record for this holder in this stock. | ||||||